Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells

Pain Physician

Volumn 11, Issue 3, 2008, Pages 343-353

  Centeno, Christopher J ^a,b   Busse, Dan ^a   Kisiday, John ^c   Keohan, Cristin ^a,b   Freeman, Michael ^d   Karli, David ^e  

^a Regenerative Sciences Inc   (United States)

^b Centeno Schultz Clinic   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e THE STEADMAN CLINIC   (United States)

Author keywords

Autologous mesenchymal stem cells; Cartilage; Knee; Osteoarthritis

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTHROSCOPIC SURGERY; ARTICULAR CARTILAGE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CASE REPORT; CASE STUDY; CELL ISOLATION; CULTURE TECHNIQUE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; ILIAC CREST; JOINT EFFUSION; JOINT MOBILITY; KNEE FRACTURE; KNEE MENISCUS; KNEE OSTEOARTHRITIS; KNEE PAIN; KNEE RADIOGRAPHY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PHYSIOTHERAPY; RANGE OF MOTION; REVIEW; SOLDIER; TISSUE REGENERATION; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; CARTILAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KNEE INJURIES; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; PAIN MEASUREMENT; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 46949103497     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Cassiede P, Dennis JE, Ma F, Caplan Al. Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro. J Bone Miner Res 1996; 11:1264-1273.
2. Chen YJ, Wurtz T, Wang CJ, Kuo YR, Yang KD, Huang HC, Wang FS. Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res 2004; 22:526-534.
3. Doucet, C. Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JR. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005; 205:228-236.
4. Gordon EM, Skotzko M, Kundu RK, Han B, Andrades J, Nimni M, Anderson WF, Hall FL. Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX. Hum Gene Ther 1997; 8:1385-1394.
5. Reddi AH, Cunningham NS. Bone induction by osteogenin and bone morphogenetic proteins. Biomaterials 1990; 11:33-34.
6. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: Growth factor content and roles in wound healing. J Dent Res 2005; 84:434-439.
7. Martineau I, Lacoste E, Gagnon G. Effects of calcium and thrombin on growth factor release from platelet concentrates: Kinetics and regulation of endothelial cell proliferation. Biomaterials 2004; 25:4489-4502.
8. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004; 91:4-15.
9. Bernardo ME, Avanzini MA, Perotti C, Cometa AM, Moretta A, Lenta E, Del Fante C, Novara F, de Silvestri A, Amendola G, Zuffardi O, Maccario R, Locatelli F. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 2007; 211:121-130.
10. Müller I, Kordowich S, Holzwarth C, Spano C, Isensee G, Staiber A, Viebahn S, Gieseke F, Langer H, Gawaz MP, Horwitz EM, Conte P, Handgretinger R, Dominici M. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 2006; 8:437-444.
11. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion, 2007; 47:1436-1446.
12. Mishra A, PavelkoT. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006; 34:1774-1778.
13. Aspenberg P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand 2004; 75:93-99.
14. Szilvassy SJ. The biology of hematopoietic stem cells. Arch Med Res 2003; 34:446-460.
15. Barry FP. Mesenchymal stem cell therapy in joint disease. Novartis Found Symp, 2003; 249:86-96; discussion 96-102, 170-174, 239-241.
16. Buckwalter JA. Mankin HJ. Articular cartilage: Degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect, 1998. 47:487-504.
17. Caplan Al. Mesenchymal stem cells. J Orthop Res 1991; 9:641-650.
18. Carter DR, Beaupré GS, Giori NJ, Helms JA. Mechanobiology of skeletal regeneration. Clin Orthop Relat Res 1998 (355 Suppl):541-55.
19. Johnstone B, Yoo JU. Autologous mesenchymal progenitor cells in articular cartilage repair. Clin Orthop Relat Res 1999; (367 Suppl):S156-62.
20. Luyten FP. Mesenchymal stem cells in osteoarthritis. Curr Opin Rheumatol 2004; 16:599-603.
21. Magne D, Vinatier C, Julien M, Weiss P, Guicheux J. Mesenchymal stem cell therapy to rebuild cartilage. Trends Mol Med 2005; EPub (10-5-05).
22. Murphy JM, Fink DJ, Hunziker EB, Barry FR Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 48:3464-3474.
23. Nevo Z, Robinson D, Horowitz S, Hasharoni A, Yayon A. The manipulated mesenchymal stem cells in regenerated skeletal tissues. Cell Transplant 1998. 7:63-70.
24. Noel D, Djouad F, Jorgense C. Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig Drugs 2002: 3:1000-1004.
25. Redman SN, Oldfield SF, Archer CW. Current strategies for articular cartilage repair. Eur Cell Mater 2005; 9:23-32; discussion 23-32.
26. Tallheden T, Dennis JE, Lennon DP, Sjögren-Jansson E, Caplan Al, Lindahl A. Phenotypic plasticity of human articular chondrocytes. J Bone Joint Surg Am 2003; 85-A Suppl 2:93-100.
27. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 1994; 76:579-592.
28. Walsh CJ, Goodman D, Caplan AI, Goldberg VM. Meniscus regeneration in a rabbit partial meniscectomy model. Tissue Eng 1999; 5:327-337.
29. Keyser KA, Morris JC, Kiem HP. Genetically modified CD34+ ceUs do not contribute to the mesenchymat compartment after autologous transplantation in the baboon. Cytotherap 2005; 7:345-352.
30. Steadman JR, Ramappa AJ, Maxwell RB, Briggs KK. An arthroscopic treatment regimen for osteoarthritis of the knee. Arthroscopy 2007; 23:948-955.
31. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994; 56:283-294.
32. D'lppolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymat stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999; 14:1115-1122.
33. Centeno CJ, Kisiday J, Freeman M, Schultz JR. Partial regeneration of the human hip via autologous bone marrow nucleated celt transfer: A case study. Pain Physician 2006; 9:253-256.
34. Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: Influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng 2006; 93:1152-1163.
35. Gao J, Caplan AI. Mesenchymal stern cells and tissue engineering for orthopaedic surgery. Chir Organi Mov 2003; 88:305-316.
36. Guo X, Wang C, Zhang Y, Xia R, Hu M, Duan C, Zhao Q, Dong L, Lu J, Qing Song Y. Repair of large articular cartilage defects with implants of autologous mesenchymal stem cells seeded into betatricalcium phosphate in a sheep model. Tissue Eng 2004; 10:1818-1829.
37. Xiang Y, Zheng Q, Jia BB, Huang GP, Xu YL, Wang JF, Pan ZJ. Ex vivo expansion and pluripotential differentiation of cryopreserved human bone marrow mesenchymal stem cells. J Zhejiang Univ Sci B 2007; 8:136-146.
38. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, Bagasra O, Prockop OJ. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 1995; 92:4857-4861.
39. Crisostomo PR, Wang M, Wairiuko GM, Morrell ED, Terrell AM, Seshadri P, Nam UH, Meldrum DR. High passage numher of stem cells adversely affects stem cell activation and myocardial protection. Shock 2006; 26:575-580.
40. Cui JH, Park K, Park SR, Min BH. Effects of low-intensity ultrasound on chondrogenic differentiation of mesenchymal stem cells embedded in polyglycolic acid: An in vivo study. Tissue Eng 2006; 12:75-82.
41. Risbud MV, Albert TJ, Guttapalli A, Vresitovic EJ, Hillibrand AS, Vaccaro AR, Shapiro IM. Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: Implications for cell-based transplantation therapy. Spine 2004; 29(:2627-2632.
42. Scutt A, Bertram P. Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif Tissue Int 1999; 64:69-77.
43. Zhang Y, Wang C, Liao W, Li Z, Guo X, Zhao Q, Duan C, Xia R. In vitro chondrogenic phenotype differentiation of bone marrow-derived mesenchymal stem cells. J Huazhong Univ Sci Technolog Med Sci 2004; 24:275-278.
44. Chrysis D, Ritzen EM, Savendahl L. Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes. J Endocrinol 2003; 176:331-337.
45. Chrysis D, Zaman F, Chagin AS, Takigawa M, Sävendahl L. Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Aktphosphatidylinositol 3′-kinase signaling pathway. Endocrinology 2005; 146:1391-1397.
46. D'Lima DD, Hashimoto S, Chen PC, Lotz MK, Colwell CW Jr. Prevention of chondrocyte apoptosis. J Bone Joint Surg Am 2001: 83-A Suppl 2(Pt 1):25-26.
47. Jones LC, Hungerford DS. The pathogenesis of osteonecrosis. Instr Course Lect 2007; 56:179-196.
48. Nakazawa F, Matsuno H, Yudoh K, Watanabe Y, Katayama R, Kimura T. Corticosteroid treatment induces chondrocyte apoptosis in an experimental arthritis model and in chondrocyte cultures. Clin Exp Rheumatol 2002: 20:773-781.
49. Li F, Jia H, Yu C. ACL reconstruction in a rabbit model using irradiated Achilles allograft seeded with mesenchymal stem cells or PDGF-B gene-transfected mesenchymal stem cells. Knee Surg Sports Traumatol Arthrosc 2007; 15:1219-1227.
50. Silverman RP, Passaretti D, Huang W, Randolph MA, Yaremchuk MJ. Injectable tissue-engineered cartilage using a fibrin gtue polymer. Plast Reconstr Surg 1999; 103:1809-1818.
51. Radice M, Brun P, Cortivo R, Scapinelli R, Battaliard C, Abatangelo G. Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. J Biomed Mater Res 2000: 50:101-109.
52. Hamilton DK, Jones-Quaidoo SM, Sansur C, Shaffrey CI, Oskouian R, Jane JA Sr. Outcomes of bone morphogenetic protein-2 in mature adults: Posterolateral non-instrument-assisted lumbar decompression and fusion. Surg Neurol 2008; 69:457-461.
53. White AP, Vaccaro AR, Hall JA, Whang PG, Friel Be, McKee MD. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion. Int Orthop 2007; 31:735-741.
54. Ishii I, Mizuta H, Sei A, Hirose J, Kudo S, Hiraki Y. Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant. J Bone Joint Surg Br 2007; 89:693-700.
55. Blaney Davidson EN, van der Kraan PM, van den Berg WB. TGF-beta and osteoarthritis. Osteoarthritis Cartilage 2007; 15:597-604.